Gadolinium News and Research

RSS
Study finds no increased risk for parkinsonism linked to use of gadolinium in MRIs

Study finds no increased risk for parkinsonism linked to use of gadolinium in MRIs

Study finds no substantial link between gadolinium exposure and parkinsonism

Study finds no substantial link between gadolinium exposure and parkinsonism

Switch to rituximab shows anti-inflammatory effect in relapsing-remitting MS

Switch to rituximab shows anti-inflammatory effect in relapsing-remitting MS

BNPs have potential to enable early diagnosis, long-term treatment of RA with minimal side effects

BNPs have potential to enable early diagnosis, long-term treatment of RA with minimal side effects

Real risk of rebound syndrome following fingolimod cessation for MS

Real risk of rebound syndrome following fingolimod cessation for MS

New chemical probe could tag cells for detection by MRI

New chemical probe could tag cells for detection by MRI

CWRU researcher to customize tobacco mosaic virus to treat human cancers

CWRU researcher to customize tobacco mosaic virus to treat human cancers

Metabolic syndrome treatment benefits MS patients

Metabolic syndrome treatment benefits MS patients

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Promising phase II results for ozanimod in MS

Promising phase II results for ozanimod in MS

Natalizumab shows relapse prevention benefits over fingolimod in MS

Natalizumab shows relapse prevention benefits over fingolimod in MS

Fingolimod trial INFORMS primary progressive MS strategy

Fingolimod trial INFORMS primary progressive MS strategy

New technique could improve heart scans for patients

New technique could improve heart scans for patients

Study explores prevalence of myocardial scars in middle-aged and older population

Study explores prevalence of myocardial scars in middle-aged and older population

GATE opens for generic equivalent to glatiramer acetate in MS

GATE opens for generic equivalent to glatiramer acetate in MS

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Agfa HealthCare awarded new three-year DR contract with Premier, Inc.

Agfa HealthCare awarded new three-year DR contract with Premier, Inc.

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

Tiny nanocrystals could be used in advanced medical imaging technologies to light up cancer cells

New MRI contrast agent detects tiny breast cancer tumors, micrometastases

New MRI contrast agent detects tiny breast cancer tumors, micrometastases

Agfa HealthCare to launch new mobile DR system with FreeView telescopic column at AHRA 2015

Agfa HealthCare to launch new mobile DR system with FreeView telescopic column at AHRA 2015